HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel A Galvão Selected Research

Oxygen (Dioxygen)

1/2015Reduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation.
6/2009A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel A Galvão Research Topics

Disease

62Prostatic Neoplasms (Prostate Cancer)
03/2024 - 12/2006
25Neoplasms (Cancer)
04/2024 - 02/2005
13Fatigue
01/2023 - 07/2008
7Obesity
01/2022 - 12/2005
6Breast Neoplasms (Breast Cancer)
12/2023 - 09/2015
5Body Weight (Weight, Body)
12/2023 - 11/2019
5Overweight
11/2022 - 12/2005
4Inflammation (Inflammations)
06/2022 - 12/2005
4Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 12/2005
4Neoplasm Metastasis (Metastasis)
12/2018 - 01/2010
3Sarcopenia
01/2023 - 06/2008
3Insulin Resistance
06/2022 - 09/2012
3Disease Progression
01/2018 - 06/2009
3Osteoporosis
12/2011 - 06/2008
2Glioma (Gliomas)
06/2023 - 09/2021
2Glioblastoma (Glioblastoma Multiforme)
06/2023 - 09/2021
2Melanoma (Melanoma, Malignant)
01/2023 - 01/2021
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 04/2014
2Weight Loss (Weight Reduction)
01/2021 - 12/2020
2Pain (Aches)
12/2018 - 01/2018
2Muscular Atrophy (Muscle Atrophy)
06/2017 - 12/2011
2Chronic Disease (Chronic Diseases)
02/2015 - 06/2008
2Type 2 Diabetes Mellitus (MODY)
06/2008 - 12/2005
1Urinary Incontinence
12/2023
1Ovarian Neoplasms (Ovarian Cancer)
10/2023
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2023
1Dysbiosis
06/2022
1Mitochondrial Diseases (Mitochondrial Disease)
06/2022
1Anorexia
06/2022
1Hypogonadism (Hypergonadotropic Hypogonadism)
06/2022
1Weight Gain
01/2022
1Hypertrophy
01/2021
1Hypoxia (Hypoxemia)
01/2021
1Lung Neoplasms (Lung Cancer)
11/2019
1Rectal Neoplasms (Rectal Cancer)
01/2018
1Bone Resorption
01/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2017
1Sleep Initiation and Maintenance Disorders (Insomnia)
01/2017
1Breast Cancer Lymphedema
01/2016
1Urogenital Neoplasms
01/2011
1Abdominal Obesity
12/2009
1Metabolic Diseases (Metabolic Disease)
12/2009
1Bone Diseases (Bone Disease)
07/2008

Drug/Important Bio-Agent (IBA)

46AndrogensIBA
03/2024 - 12/2006
8MyokinesIBA
04/2024 - 01/2021
6Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2015
5Proteins (Proteins, Gene)FDA Link
06/2022 - 12/2005
4Hormones (Hormone)IBA
03/2024 - 06/2008
4Testosterone (Sustanon)FDA Link
01/2018 - 06/2008
3CytokinesIBA
12/2023 - 01/2021
3Prostate-Specific Antigen (Semenogelase)IBA
01/2021 - 07/2008
3Insulin (Novolin)FDA Link
01/2018 - 06/2009
3LipidsIBA
04/2014 - 06/2009
2CreatineIBA
01/2019 - 01/2018
2Therapeutic UsesIBA
01/2019 - 06/2008
2Oxygen (Dioxygen)IBA
01/2015 - 06/2009
1Complement System Proteins (Complement)IBA
06/2022
1MicroRNAs (MicroRNA)IBA
01/2021
1Interleukin-15 (Interleukin 15)IBA
01/2021
1DecorinIBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2021
1Cysteine (L-Cysteine)FDA Link
01/2021
1MyostatinIBA
01/2021
1IntegrinsIBA
01/2021
1Oncostatin MIBA
01/2021
1Interleukin-10 (Interleukin 10)IBA
01/2021
1N-acetyltalosaminuronic acid (NAT)IBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Clostridium perfringens epsilon-toxinIBA
11/2019
1MineralsIBA
01/2019
1Opiate AlkaloidsIBA
01/2018
1ProcollagenIBA
01/2018
1Aromatase InhibitorsIBA
01/2018
1collagen type I trimeric cross-linked peptideIBA
01/2018
1CholesterolIBA
02/2015
1HDL CholesterolIBA
02/2015
1Leuprolide (Lupron)FDA LinkGeneric
01/2014
1Acetates (Acetic Acid Esters)FDA Link
01/2014
1Lipoproteins (Lipoprotein)IBA
09/2012
1C-Reactive ProteinIBA
01/2010

Therapy/Procedure

56Therapeutics
03/2024 - 06/2008
15Resistance Training
11/2023 - 02/2005
11Radiotherapy
11/2023 - 12/2009
6Drug Therapy (Chemotherapy)
11/2023 - 06/2008
6Aftercare (After-Treatment)
01/2022 - 02/2005
4Caloric Restriction
12/2023 - 12/2020
3Prostatectomy (Retropubic Prostatectomy)
12/2023 - 01/2017
3Exercise Therapy (Therapy, Exercise)
01/2023 - 12/2006
3Neoadjuvant Therapy
01/2021 - 06/2017
3Contraindications
01/2018 - 07/2009
2Length of Stay
12/2023 - 06/2013
2Chemoradiotherapy
06/2023 - 09/2021
2Glycemic Control
12/2009 - 06/2009
1Cytoreduction Surgical Procedures
10/2023
1Adjuvant Chemoradiotherapy
06/2023
1Cystectomy
01/2023
1Fat-Restricted Diet (Diet, Fat Restricted)
01/2022
1Continuity of Patient Care
01/2021
1Palliative Care (Palliative Therapy)
04/2019
1Investigational Therapies (Experimental Therapy)
03/2014